Rituxan Lymphoma Tx Works Without Radiation MedPage Today A dose-adjusted, infusion approach to aggressive chemotherapy with rituximab (Rituxan) may allow patients with primary mediastinal B-cell lymphoma to skip radiation, a small uncontrolled trial suggested. Among 51 such treated patients, 97% survived and ... New Strategy Helps Young Lymphoma Patients Avoid Radiation Treatment |
